Mustang Bio Ebitda Over Time
| MBIO Stock | USD 0.18 0 2.50% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Mustang Bio Performance and Mustang Bio Correlation. Mustang |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.37) | Revenue Per Share (0) | Return On Assets (0.56) | Return On Equity (3.22) |
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Ebitda Analysis
Compare Mustang Bio and related stocks such as Valneva SE ADR, Dominari Holdings, and Procter Gamble Ebitda Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VALN | 930 K | (1 M) | (7.6 M) | (12.8 M) | (11.2 M) | (1.2 M) | (908 K) | 7.4 M | 14.4 M | 10.1 M | (45.3 M) | (46.9 M) | (113.2 M) | (86.5 M) | (82.2 M) |
| DOMH | 400 K | (5.2 M) | (4 M) | (12.4 M) | (20.8 M) | 35.2 M | (3.2 M) | (2.7 M) | (9.6 M) | (7.2 M) | (736 K) | (11.3 M) | (5.8 M) | (21.4 M) | (20.3 M) |
| PG | 1.7 B | 18.3 B | 18.8 B | 18.7 B | 17.6 B | 17 B | 16.5 B | 16.7 B | 17.7 B | 19.3 B | 20.9 B | 21.2 B | 21.8 B | 25.1 B | 12.9 B |
| HPQ | 1.1 B | 34.7 B | 13.8 B | 14.8 B | 8 B | 4.6 B | 4.9 B | 5.1 B | 5.2 B | 5.2 B | 6.7 B | 6.6 B | 5.8 B | 6.7 B | 8.1 B |
| JPM | 390.2 M | 49.7 B | 63.9 B | (12.5 B) | (4.6 B) | (4.2 B) | (1.6 B) | (1.2 B) | (1.8 B) | (2 B) | (2.8 B) | (2.3 B) | (2 B) | (1.8 B) | (1.7 B) |
| MMM | 1.6 B | 7.4 B | 7.8 B | 8 B | 8.5 B | 8.4 B | 8.7 B | 9.4 B | 8.7 B | 5.9 B | 6.4 B | 7.4 B | 8.4 B | (9.1 B) | (8.7 B) |
| GE | 3.2 B | 34.6 B | 32.8 B | 28.9 B | 29.3 B | 14.3 B | 16.9 B | 8.2 B | 9.9 B | 6.9 B | 10.2 B | 7 B | 4.8 B | 8.5 B | 8.1 B |
| KO | 1.1 B | 13.3 B | 14.2 B | 13.9 B | 11.8 B | 12.4 B | 10.7 B | 8.8 B | 10.3 B | 13.1 B | 12.7 B | 16.2 B | 13.8 B | 12.4 B | 8.2 B |
| INTC | 106.1 M | 17.7 B | 14.9 B | 12.6 B | 15.6 B | 14.3 B | 13.2 B | 18.1 B | 23.5 B | 33.6 B | 38 B | 36.5 B | 15.4 B | 93 M | 88.3 M |
| CSCO | 600 K | 13.7 B | 14.3 B | 13.1 B | 14.7 B | 16 B | 16.2 B | 16.5 B | 17.6 B | 16.8 B | 16.4 B | 16.8 B | 18 B | 20.7 B | 21.7 B |
Mustang Bio and related stocks such as Valneva SE ADR, Dominari Holdings, and Procter Gamble Ebitda description
My Equities
My Current Equities and Potential Positions
Additional Information and Resources on Investing in Mustang Stock
When determining whether Mustang Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mustang Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mustang Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mustang Bio Stock:Check out Mustang Bio Performance and Mustang Bio Correlation. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Mustang Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.